TEMPLATE: CLINICAL STUDY PROTOCOL

1.1.3 Compliance with Good Laboratory Practice regulations (21 CFR Part 58) Specify whether or not the unpublished and/or published laboratory and animal studies of the device, described above, were conducted in a laboratory or facility that is certified as operating in full compliance with the FDA’s GLP … ................
................